ALLERGAN TAZORAC PLAQUE PSORIASIS REDUCTION SUSTAINED "UP TO 12 WEEKS" AFTER TREATMENT; RETINOID GEL WILL BE LAUNCHED IN MID-JULY FOR PSORIASIS, ACNE
Executive Summary
Allergan's once-daily Tazorac (tazarotene) maintains reductions in plaque psoriasis elevation, scaling and erythema severity 12 weeks after treatment, according to clinical study data included in Tazorac labeling.